Rhythm Pharmaceuticals: Q2 Earnings Insights

Rhythm Pharmaceuticals RYTM reported its Q2 earnings results on Tuesday, August 2, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Rhythm Pharmaceuticals beat estimated earnings by 6.32%, reporting an EPS of $-0.89 versus an estimate of $-0.95.

Revenue was up $2.04 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 10.11% drop in the share price the next day.

Here's a look at Rhythm Pharmaceuticals's past performance:

To track all earnings releases for Rhythm Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.